These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9444402)

  • 41. Interference of ofloxacin with determination of urinary porphyrins.
    Schoenfeld N; Mamet R
    Clin Chem; 1994 Mar; 40(3):417-9. PubMed ID: 8131278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A reverse-phase, isocratic high-performance liquid chromatography assay for levofloxacin.
    Tobin CM; Sunderland J; White LO; MacGowan AP
    J Antimicrob Chemother; 1999 Mar; 43(3):434-5. PubMed ID: 10223609
    [No Abstract]   [Full Text] [Related]  

  • 43. Simple microbiological method for the identification of antimicrobial agents prescribed in general practice.
    Millar MR; Langdale P
    J Clin Microbiol; 1985 May; 21(5):741-4. PubMed ID: 3889045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of ofloxacin in plasma and urine by liquid chromatography.
    Le Coguic A; Bidault R; Farinotti R; Dauphin A
    J Chromatogr; 1988 Dec; 434(1):320-3. PubMed ID: 3243831
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of fluoroquinolones in urinary specimens from patients undergoing anti-tuberculous therapy.
    Chan CY; Tsang DS; Chan TL; Yew WW; Cheung SW; Cheng AF
    Chemotherapy; 1998; 44(1):7-11. PubMed ID: 9444402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New fluoroquinolone antibiotics.
    Drug Ther Bull; 1999 Jan; 37(1):6-8. PubMed ID: 10562769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levofloxacin, a second-generation fluoroquinolone.
    North DS; Fish DN; Redington JJ
    Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of side effects of levofloxacin versus other fluoroquinolones.
    Carbon C
    Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of levofloxacin in the antibiotic prophylaxis for diagnostic procedures in urology].
    Trinchieri A; Mangiarotti B; Lizzano R
    Arch Ital Urol Androl; 2002 Mar; 74(1):33-9. PubMed ID: 12053449
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.